A unique interaction between polyamine and multidrug resistance (P-glycoprotein) transporters in cultured Chinese hamster ovary cells transfected with mouse mdr-1 gene

Biochemical Pharmacology

Volumn 56, Issue 2, 1998, Pages 181-187

  Aziz, Shewan M ^a   Worthen, David R ^d   Yatin, Mustafa ^b,c   Ain, Kenneth B ^b,c   Crooks, Peter A ^d  

^a HENRY FORD HOSPITAL   (United States)

^b LEXINGTON VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^d University of Kentucky   (United States)

Author keywords

Multiple drug resistance; P glycoprotein; Polyamine transport; Polymer of spermine

Indexed keywords

CYCLOSPORIN A; DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; PACLITAXEL; POLYAMINE; SPERMINE DERIVATIVE; VALSPODAR;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACCUMULATION; GENETIC TRANSCRIPTION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CARRIER PROTEINS; CHO CELLS; CRICETINAE; CRICETULUS; DOXORUBICIN; ETOPOSIDE; FLOW CYTOMETRY; MICE; P-GLYCOPROTEIN; PACLITAXEL; PROTEIN BINDING; SPERMIDINE; TRANSFECTION;

EID: 0031784468     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00132-4     Document Type: Article

References (38)

1. Pegg AE, Recent advances in the biochemistry of polyamines in eukaryotes. Biochem J 234: 249-262, 1986.
2. Heby O, Role of polyamines in cell growth and differentiation. Differentiation 19: 1-20, 1991.
3. Morgan L and David ML, Polyamines and cellular regulation: Perspectives. Biochem Soc Trans 18: 1080-1088, 1990.
4. Pegg AE, Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer 48: 759-764, 1988.
5. Russell DH and Durie BGM, Polyamines as biochemical markers of normal and malignant growth. Progress in Cancer Research and Therapy, Vol. 8. Raven Press, New York, 1978.
6. Basu HS, Pellarin M, Feuerstein BG, Shirahata A, Samejima K, Deen DF and Marton LJ, Interaction of a polyamine analogue, 1,19-bis-(ethylamino)-5,10,15-triazanonadecane (BE-4-4-4-4), with DNA and effect on growth, survival, and polyamine levels in seven human brain tumor cell lines. Cancer Res 53: 3948-3955, 1993.
7. Pegg A and McCann P, Polyamine metabolism and function. Am J Physiol 243: C212-C221, 1982.
8. Seiler N and Dezeure F, Polyamine transport in mammalian cells. Int J Biochem 22: 211-218, 1990.
9. Toursarkissian B, Endean ED and Aziz SM, Characterization of polyamine transport in rat aortic smooth muscle cells. J Surg Res 57: 401-408, 1994.
10. Aziz SM and Olson JW, Multiple polyamine transport pathways in cultured pulmonary artery smooth muscle cells: Regulation by hypoxia. Am J Respir Cell Mol Biol 10: 160-166, 1994.
11. Holly JH, Mather A, Wheelhouse RT, Cullis PM, Hartley JA, Bingharm JP and Cohen GM, Targeting of tumor cells and DNA by a chlorabucil-spermidine conjugate. Cancer Res 52: 4190-4196, 1992.
12. Gottesman MM, How cancer cells evade chemotherapy: Sixteenth Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 53: 747-754, 1993.
13. Tiirikainen MI and Krusius T, Multidrug resistance. Ann Med 23: 509-520, 1991.
14. Kartner N, Riordan JR and Ling V, Cell surface P-glycoprotein associated with multidrug-resistance in mammalian cell lines. Science 221: 1285-1288, 1983.
15. Juranka PF, Zastawny RL and Ling V, P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins. FASEB 3: 2583-2592, 1989.
16. Ford JM and Hait WN, Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 42: 155-199, 1990.
17. Safa AR, Photoaffinity labeling of P-glycoprotein in multidrug-resistant cells. Cancer Invest 11: 46-56, 1993.
18. Mickisch GG, Pai LH and Pastan I, Monoclonal antibody MRK16 reverses the multidrug resistance of multidrug-resistant transgenic mice. Cancer Res 52: 4427-4432, 1992.
19. Gosland MP, Lum BL, and Sikic BI, Reversal by cefoperazone of resistance to etoposide, doxorubicin, and vinblastine in multidrug resistant human sarcoma cells. Cancer Res 49: 6901-6905, 1989.
20. Hoof T, Deer A, Hadam M, Riordan J and Tuler B, Cystic fibrosis-type mutational analysis in the ATP-binding cassette transporter signature of human P-glycoprotein MDR1. J Biol Chem 269: 20575-20583, 1994.
21. Nielsen D and Skovsgaard T, P-glycoprotein as multidrug transporter: A critical review of current multidrug resistant cell lines. Biochim Biophys Acta 139: 169-183, 1992.
22. Aziz SM, Gosland MP, Crooks PA and Olson JW, A novel polymeric spermine conjugate inhibits polyamine transport in pulmonary artery smooth muscle cells. J Pharmacol Exp Ther 274: 181-186, 1995.
23. Gosland MP, Gillespie MN, Tsuboi CP, Tofig S, Olson JW, Crooks PA and Aziz SM, Reversal of doxorubicin, etoposide, vinblastine, and taxol resistance in multidrug resistant human sarcoma cells by a polymer of spermine. Cancer Chemother Pharmacol 37: 593-600, 1996.
24. Aziz SM, Crooks PA, Tofiq SF, Olson JW, Gillespie MN and Gosland MP, The potential of a novel polyamine transport inhibitor in cancer chemotherapy. J Pharmacol Exp Ther 278: 185-192, 1996.
25. Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM and Danielsen M, Lipofectin: A highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 84: 7413-7417, 1987.
26. Harker G and Sikic B, Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA. Cancer Res 45: 4091-4096, 1985.
27. Robinson BI, The role of the MDR1 gene in multidrug resistance in vitro and in vivo. Biochem Pharmacol 43: 95-102, 1992.
28. Gosland M, Tsuboi C, Hoffman T, Goodin S and Vore M, 17β-Estradiol glucuronide: An inducer of cholestasis and a physiological substrate for multidrug resistance transporter. Cancer Res 53: 5382-5385, 1993.
29. Mandel J-L and Flintoff WF, Isolation of mutant mammalian cells altered in polyamine transport. J Cell Physiol 97: 335-344, 1978.
30. Heaton MA and Flintoff WF, Methylglyoxal-bis(guanylhydrazone)-resistant Chinese hamster ovary cells: Genetic evidence that more than a single locus controls uptake. J Cell Physiol 136: 133-139, 1988.
31. Valverde MA, Diaz M, Sepulveda FV, Gill DR and Higgins CF, Volume-regulated chloride channels associated with the human multidrug resistance P-glycoprotein. Nature 355: 830-833, 1992.
32. Chen C-J, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM and Roninson IB, Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47: 381-389, 1986.
33. Gros P, Croop J and Housman D, Mammalian multidrug gene: Complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47: 371-380, 1986.
34. Gollapudi S, McDonald T, Gardner P and Gupta S, Abnormal chloride conductance in multidrug resistant HL60/AR cells. Cancer Lett 66: 83-89, 1992.
35. Breuer W, Ausiello DA and Cabantchik IZ, Induction of multidrug resistance downregulates the expression of CFTR in colon epithelial cells. Am J Physiol 265: C1711-C1715, 1993.
36. Kashiwagi K, Hosokawa N and Igarashi K, Isolation of polyamine transport-deficient mutants of Escherichia coli and cloning of genes for polyamine transport proteins. J Biol Chem 265: 20893-20897, 1990.
37. Kashiwagi K, Miyamoto S, Suzuki F, Kobayashi H and Igarashi K, Excretion of putrescine by putrescine-ornithine antiporter encoded by the potE gene of Escherichia coli. Proc Natl Acad Sci USA 89: 4529-4533, 1992.
38. Wang X, Wall DM, Parkin JD, Zalcberg JR and Kemm RE, P-glycoprotein expression in classical multi-drug resistant leukaemia cells does not correlate with enhanced chloride channel activity. Clin Exp Pharmacol Physiol 21: 101-108, 1994.